Goldman Sachs Downgrades Humana (HUM) to Neutral

Article Stock Quotes (4) Comments (0)

Goldman Sachs downgraded Humana (NYSE: HUM) from Buy to Neutral with a price target of $90 (down from $98).

The firm sees more upside in others areas of their coverage. Specifically, the firm's Buy-rated names in managed care include Health Net (NYSE: HNT), Coventry (NYSE: CVH), and WellCare (NYSE: WCG).

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $81.39 yesterday, with a 52 week range of $65.20-$96.46.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
• Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
• TD Securities Downgrades Nordion Inc (NDZ) to Reduce

Create E-mail Alert Related Categories

Analyst PT Change, Downgrades

Related Entities

Goldman Sachs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?